Clinical outcomes after revascularization for pediatric moyamoya disease and syndrome: A single-center series.


Journal

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
ISSN: 1532-2653
Titre abrégé: J Clin Neurosci
Pays: Scotland
ID NLM: 9433352

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 30 11 2019
revised: 25 06 2020
accepted: 06 07 2020
entrez: 19 10 2020
pubmed: 20 10 2020
medline: 12 1 2021
Statut: ppublish

Résumé

Moyamoya is a progressive cerebrovascular arteriopathy that affects children of any age. The goal of this study was to determine imaging and clinical outcomes as well as complication rates in a pediatric cohort undergoing either a combined direct/indirect or indirect-only revascularization approach. Patients with moyamoya disease or syndrome ≤ 18 years of age at the time of initial surgery were identified, and clinical data were collected retrospectively. Over a 12-year period, 26 patients underwent revascularization procedures on 49 hemispheres with a median follow-up of 2.6 years from surgery. Median age at surgery was 7.3 years (range 1.4-18.0 years). Thirty-three hemispheres (67.3%) underwent combined revascularization with a direct bypass and encephalomyosynangiosis, and sixteen hemispheres (32.7%) underwent indirect-only revascularization. The rate of 30-day perioperative complication was 10.2%, and the rate of postoperative clinical stroke by end of follow-up was 10.2% by hemisphere. There was a 5.7% rate of intraoperative bypass failure requiring conversion to an indirect revascularization approach. On follow-up imaging, 96.9% of direct bypasses remained patent. On multivariate analysis, higher preoperative Pediatric Stroke Outcome Measure (PSOM) scores were associated with lower rates of good clinical outcome on follow-up (unit OR 0.03; p = 0.03). Patients with age < 5.4 years had lower rates of good clinical outcome on follow-up. In this North American cohort, both combined direct/indirect and indirect only revascularization techniques were feasible. However, younger children < 5.4 years of age have worse outcomes than older children, similar to east Asian cohorts.

Identifiants

pubmed: 33070883
pii: S0967-5868(20)31354-0
doi: 10.1016/j.jocn.2020.07.016
pmc: PMC7573194
mid: NIHMS1623224
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

137-143

Subventions

Organisme : NINDS NIH HHS
ID : U54 NS065705
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Dev Med Child Neurol. 2015 Sep;57(9):786-7
pubmed: 25683905
J Neurosurg Pediatr. 2018 Aug;22(2):173-180
pubmed: 29856299
Neurosurgery. 2004 Apr;54(4):840-4; discussion 844-6
pubmed: 15046649
Skull Base. 2005 Feb;15(1):15-26
pubmed: 16148981
J Neurosurg Pediatr. 2018 Nov 16;23(2):198-203
pubmed: 30497164
Neurosurg Focus. 2009 Apr;26(4):E11
pubmed: 19335127
Neurosurg Focus. 2008;24(2):E16
pubmed: 18275292
Arch Neurol. 1969 Mar;20(3):288-99
pubmed: 5775283
J Neurosurg Anesthesiol. 1998 Jan;10(1):37-41
pubmed: 9438618
Neurosurg Rev. 2016 Oct;39(4):615-23
pubmed: 27180559
Neurosurgery. 2017 Feb 1;80(2):201-209
pubmed: 28175916
J Child Neurol. 2017 Oct;32(11):924-929
pubmed: 28715924
Childs Nerv Syst. 2008 Jul;24(7):827-32
pubmed: 18066556
Neurol Med Chir (Tokyo). 2018 Jun 15;58(6):240-246
pubmed: 29780072
Pediatr Neurol. 2017 Oct;75:48-54
pubmed: 28778481
Neurosurgery. 2017 Jun 1;80(6):950-956
pubmed: 28327981
Childs Nerv Syst. 2015 May;31(5):765-72
pubmed: 25722049
Cerebrovasc Dis. 2015;39(2):75-81
pubmed: 25573764
Childs Nerv Syst. 2005 May;21(5):358-64
pubmed: 15696334
J Neurosurg. 2004 Feb;100(2 Suppl Pediatrics):142-9
pubmed: 14758941
Stroke. 2012 Jun;43(6):1602-8
pubmed: 22474056
World Neurosurg. 2018 May;113:e190-e199
pubmed: 29432946

Auteurs

Ramin A Morshed (RA)

Department of Neurological Surgery, University of California, San Francisco, CA, USA.

Adib A Abla (AA)

Department of Neurological Surgery, University of California, San Francisco, CA, USA.

Daniel Murph (D)

Department of Radiology, University of California, San Francisco, CA, USA.

Jasmin M Dao (JM)

Departments of Neurology and Pediatrics, University of California, San Francisco, CA, USA.

Ethan A Winkler (EA)

Department of Neurological Surgery, University of California, San Francisco, CA, USA.

Jan-Karl Burkhardt (JK)

Department of Neurosurgery, Baylor College of Medicine Medical Center, Houston, TX, USA.

Kathleen Colao (K)

Departments of Neurology and Pediatrics, University of California, San Francisco, CA, USA.

Steven W Hetts (SW)

Department of Radiology, University of California, San Francisco, CA, USA.

Heather J Fullerton (HJ)

Departments of Neurology and Pediatrics, University of California, San Francisco, CA, USA.

Michael T Lawton (MT)

Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.

Nalin Gupta (N)

Department of Neurological Surgery, University of California, San Francisco, CA, USA.

Christine K Fox (CK)

Departments of Neurology and Pediatrics, University of California, San Francisco, CA, USA. Electronic address: christine.fox@ucsf.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH